BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 23385442)

  • 1. Screening outcomes in older US women undergoing multiple mammograms in community practice: does interval, age, or comorbidity score affect tumor characteristics or false positive rates?
    Braithwaite D; Zhu W; Hubbard RA; O'Meara ES; Miglioretti DL; Geller B; Dittus K; Moore D; Wernli KJ; Mandelblatt J; Kerlikowske K;
    J Natl Cancer Inst; 2013 Mar; 105(5):334-41. PubMed ID: 23385442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of screening mammography by frequency, breast density, and postmenopausal hormone therapy.
    Kerlikowske K; Zhu W; Hubbard RA; Geller B; Dittus K; Braithwaite D; Wernli KJ; Miglioretti DL; O'Meara ES;
    JAMA Intern Med; 2013 May; 173(9):807-16. PubMed ID: 23552817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cumulative Probability of False-Positive Results After 10 Years of Screening With Digital Breast Tomosynthesis vs Digital Mammography.
    Ho TH; Bissell MCS; Kerlikowske K; Hubbard RA; Sprague BL; Lee CI; Tice JA; Tosteson ANA; Miglioretti DL
    JAMA Netw Open; 2022 Mar; 5(3):e222440. PubMed ID: 35333365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast Tumor Prognostic Characteristics and Biennial vs Annual Mammography, Age, and Menopausal Status.
    Miglioretti DL; Zhu W; Kerlikowske K; Sprague BL; Onega T; Buist DS; Henderson LM; Smith RA;
    JAMA Oncol; 2015 Nov; 1(8):1069-77. PubMed ID: 26501844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cumulative probability of false-positive recall or biopsy recommendation after 10 years of screening mammography: a cohort study.
    Hubbard RA; Kerlikowske K; Flowers CI; Yankaskas BC; Zhu W; Miglioretti DL
    Ann Intern Med; 2011 Oct; 155(8):481-92. PubMed ID: 22007042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mammographic screening interval in relation to tumor characteristics and false-positive risk by race/ethnicity and age.
    O'Meara ES; Zhu W; Hubbard RA; Braithwaite D; Kerlikowske K; Dittus KL; Geller B; Wernli KJ; Miglioretti DL
    Cancer; 2013 Nov; 119(22):3959-67. PubMed ID: 24037812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Collaborative Modeling of the Benefits and Harms Associated With Different U.S. Breast Cancer Screening Strategies.
    Mandelblatt JS; Stout NK; Schechter CB; van den Broek JJ; Miglioretti DL; Krapcho M; Trentham-Dietz A; Munoz D; Lee SJ; Berry DA; van Ravesteyn NT; Alagoz O; Kerlikowske K; Tosteson AN; Near AM; Hoeffken A; Chang Y; Heijnsdijk EA; Chisholm G; Huang X; Huang H; Ergun MA; Gangnon R; Sprague BL; Plevritis S; Feuer E; de Koning HJ; Cronin KA
    Ann Intern Med; 2016 Feb; 164(4):215-25. PubMed ID: 26756606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of mammography screening interval on breast cancer diagnosis by menopausal status and BMI.
    Dittus K; Geller B; Weaver DL; Kerlikowske K; Zhu W; Hubbard R; Braithwaite D; O'Meara ES; Miglioretti DL;
    J Gen Intern Med; 2013 Nov; 28(11):1454-62. PubMed ID: 23760741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors Associated With Rates of False-Positive and False-Negative Results From Digital Mammography Screening: An Analysis of Registry Data.
    Nelson HD; O'Meara ES; Kerlikowske K; Balch S; Miglioretti D
    Ann Intern Med; 2016 Feb; 164(4):226-35. PubMed ID: 26756902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term outcomes of screening mammography using computer-aided detection: a population-based study of medicare enrollees.
    Fenton JJ; Xing G; Elmore JG; Bang H; Chen SL; Lindfors KK; Baldwin LM
    Ann Intern Med; 2013 Apr; 158(8):580-7. PubMed ID: 23588746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tipping the balance of benefits and harms to favor screening mammography starting at age 40 years: a comparative modeling study of risk.
    van Ravesteyn NT; Miglioretti DL; Stout NK; Lee SJ; Schechter CB; Buist DS; Huang H; Heijnsdijk EA; Trentham-Dietz A; Alagoz O; Near AM; Kerlikowske K; Nelson HD; Mandelblatt JS; de Koning HJ
    Ann Intern Med; 2012 May; 156(9):609-17. PubMed ID: 22547470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tailoring Breast Cancer Screening Intervals by Breast Density and Risk for Women Aged 50 Years or Older: Collaborative Modeling of Screening Outcomes.
    Trentham-Dietz A; Kerlikowske K; Stout NK; Miglioretti DL; Schechter CB; Ergun MA; van den Broek JJ; Alagoz O; Sprague BL; van Ravesteyn NT; Near AM; Gangnon RE; Hampton JM; Chandler Y; de Koning HJ; Mandelblatt JS; Tosteson AN;
    Ann Intern Med; 2016 Nov; 165(10):700-712. PubMed ID: 27548583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variability of interpretive accuracy among diagnostic mammography facilities.
    Jackson SL; Taplin SH; Sickles EA; Abraham L; Barlow WE; Carney PA; Geller B; Berns EA; Cutter GR; Elmore JG
    J Natl Cancer Inst; 2009 Jun; 101(11):814-27. PubMed ID: 19470953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Collaborative Modeling to Compare Different Breast Cancer Screening Strategies: A Decision Analysis for the US Preventive Services Task Force.
    Trentham-Dietz A; Chapman CH; Jayasekera J; Lowry KP; Heckman-Stoddard BM; Hampton JM; Caswell-Jin JL; Gangnon RE; Lu Y; Huang H; Stein S; Sun L; Gil Quessep EJ; Yang Y; Lu Y; Song J; Muñoz DF; Li Y; Kurian AW; Kerlikowske K; O'Meara ES; Sprague BL; Tosteson ANA; Feuer EJ; Berry D; Plevritis SK; Huang X; de Koning HJ; van Ravesteyn NT; Lee SJ; Alagoz O; Schechter CB; Stout NK; Miglioretti DL; Mandelblatt JS
    JAMA; 2024 Jun; 331(22):1947-1960. PubMed ID: 38687505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cumulative risk of false-positive results in the Norwegian Breast Cancer Screening Program: updated results.
    Roman M; Hubbard RA; Sebuodegard S; Miglioretti DL; Castells X; Hofvind S
    Cancer; 2013 Nov; 119(22):3952-8. PubMed ID: 23963877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Annual Screening Mammography Associated With Lower Stage Breast Cancer Compared With Biennial Screening.
    Moorman SEH; Pujara AC; Sakala MD; Neal CH; Maturen KE; Swartz L; Egloff H; Helvie MA
    AJR Am J Roentgenol; 2021 Jul; 217(1):40-47. PubMed ID: 33955776
    [No Abstract]   [Full Text] [Related]  

  • 17. Biennial versus annual mammography and the risk of late-stage breast cancer.
    White E; Miglioretti DL; Yankaskas BC; Geller BM; Rosenberg RD; Kerlikowske K; Saba L; Vacek PM; Carney PA; Buist DS; Oestreicher N; Barlow W; Ballard-Barbash R; Taplin SH
    J Natl Cancer Inst; 2004 Dec; 96(24):1832-9. PubMed ID: 15601639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance of first mammography examination in women younger than 40 years.
    Yankaskas BC; Haneuse S; Kapp JM; Kerlikowske K; Geller B; Buist DS;
    J Natl Cancer Inst; 2010 May; 102(10):692-701. PubMed ID: 20439838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance of Screening Ultrasonography as an Adjunct to Screening Mammography in Women Across the Spectrum of Breast Cancer Risk.
    Lee JM; Arao RF; Sprague BL; Kerlikowske K; Lehman CD; Smith RA; Henderson LM; Rauscher GH; Miglioretti DL
    JAMA Intern Med; 2019 May; 179(5):658-667. PubMed ID: 30882843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variation in false-positive rates of mammography reading among 1067 radiologists: a population-based assessment.
    Tan A; Freeman DH; Goodwin JS; Freeman JL
    Breast Cancer Res Treat; 2006 Dec; 100(3):309-18. PubMed ID: 16819566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.